Abstract
ABSTRACT It has been found that around 30% of patients of differentiated thyroid cancer with skeletal metastasis alone showed complete remission. Laboratory studies have explained a mechanism of bone metastasis where in the first premetastatic niches are formed, leading on to the formation of micrometastasis, and then on to overt metastasis. In view of the above, identifying patients who are at the micrometastatic stage can help establish a separate category of patients who would require a lower dose of radioactive iodine than those with overt metastasis. A diagnostic iodine-131 whole-body scan with single-photon emission computed tomography-computed tomography can help in identifying this category of patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
